申请人:Albert Rainer
公开号:US20100087491A1
公开(公告)日:2010-04-08
The invention relates to novel diaryl oxadiazole compounds of Formula I:
in which all the variables are as defined in the specification; to their preparation and to their use in the treatment of disorder or disease mediated by lymphocytes.
本发明涉及一种新的二芳基噁二唑化合物(Formula I),其中所有变量如规范中所定义;其制备方法以及它们在治疗淋巴细胞介导的疾病或紊乱中的应用。